Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 54

1.

UNR/CSDE1 Expression Is Critical to Maintain Invasive Phenotype of Colorectal Cancer through Regulation of c-MYC and Epithelial-to-Mesenchymal Transition.

Martinez-Useros J, Garcia-Carbonero N, Li W, Fernandez-Aceñero MJ, Cristobal I, Rincon R, Rodriguez-Remirez M, Borrero-Palacios A, Garcia-Foncillas J.

J Clin Med. 2019 Apr 25;8(4). pii: E560. doi: 10.3390/jcm8040560.

2.

Post-translational regulation could determine functional differences between SET alpha and beta isoforms in chronic lymphocytic leukaemia.

Cristóbal I, Sanz-Alvarez M, Luque M, Rojo F, García-Foncillas J.

Br J Haematol. 2019 Apr 24. doi: 10.1111/bjh.15935. [Epub ahead of print] No abstract available.

PMID:
31020656
3.

Letter by Cristóbal et al Regarding Article, "Protein Phosphatase 2A Regulates Cardiac Na+ Channels".

Cristóbal I, Sanz-Alvarez M, Luque M, Rojo F, García-Foncillas J.

Circ Res. 2019 Apr 12;124(8):e59. doi: 10.1161/CIRCRESAHA.119.314905. No abstract available.

PMID:
30973817
4.

The Role of MicroRNAs in Hepatoblastoma Tumors.

Cristóbal I, Sanz-Álvarez M, Luque M, Caramés C, Rojo F, García-Foncillas J.

Cancers (Basel). 2019 Mar 22;11(3). pii: E409. doi: 10.3390/cancers11030409. Review.

5.

Deregulation of SET is Associated with Tumor Progression and Predicts Adverse Outcome in Patients with Early-Stage Colorectal Cancer.

Cristóbal I, Torrejón B, Rubio J, Santos A, Pedregal M, Caramés C, Zazo S, Luque M, Sanz-Alvarez M, Madoz-Gúrpide J, Rojo F, García-Foncillas J.

J Clin Med. 2019 Mar 12;8(3). pii: E346. doi: 10.3390/jcm8030346.

6.

Mycosis fungoides progression could be regulated by microRNAs.

Manso R, Martínez-Magunacelaya N, Eraña-Tomás I, Monsalvez V, Rodríguez-Peralto JL, Ortiz-Romero PL, Santonja C, Cristóbal I, Piris MA, Rodríguez-Pinilla SM.

PLoS One. 2018 Jun 12;13(6):e0198477. doi: 10.1371/journal.pone.0198477. eCollection 2018.

7.

Analysis of Potential Alterations Affecting SETBP1 as a Novel Contributing Mechanism to Inhibit PP2A in Colorectal Cancer Patients.

Torrejón B, Cristóbal I, Caramés C, Prieto-Potín I, Chamizo C, Santos A, Sanz-Alvarez M, Serna-Blasco R, Luque M, Madoz-Gúrpide J, Rojo F, García-Foncillas J.

World J Surg. 2018 Nov;42(11):3771-3778. doi: 10.1007/s00268-018-4684-9.

PMID:
29796729
8.

Dissecting the therapeutic implications of the complex SMAD4 regulatory network in metastatic colorectal cancer.

Cristóbal I, Torrejón B, Santos A, Luque M, Sanz-Alvarez M, Rojo F, García-Foncillas J.

Eur J Surg Oncol. 2018 Aug;44(8):1283-1284. doi: 10.1016/j.ejso.2018.04.021. Epub 2018 May 9. No abstract available.

PMID:
29778618
9.

Potential Therapeutic Impact of miR-145 Deregulation in Colorectal Cancer.

Cristóbal I, Sanz-Alvarez M, Torrejón B, Santos A, Luque M, Rojo F, García-Foncillas J.

Mol Ther. 2018 Jun 6;26(6):1399-1400. doi: 10.1016/j.ymthe.2018.05.008. Epub 2018 May 18. No abstract available.

10.

Comment on 'MicroRNA-199b-5p attenuates TGF-β1-induced epithelial-mesenchymal transition in hepatocellular carcinoma'.

Cristóbal I, Santos A, González S, Luque M, Torrejón B, Rojo F, García-Foncillas J.

Br J Cancer. 2018 Apr;118(7):1028-1029. doi: 10.1038/s41416-018-0013-1. Epub 2018 Mar 19. No abstract available.

11.

Potential contribution of SET and c-MYC deregulation to promote extracellular matrix remodelling in hepatocellular carcinoma.

Cristóbal I, Torrejón B, Rojo F, García-Foncillas J.

Br J Pharmacol. 2018 Feb;175(3):573-574. doi: 10.1111/bph.14108. Epub 2018 Jan 5. No abstract available.

12.

PP2A regulates signaling through hormonal receptors in breast cancer with important therapeutic implications.

Cristóbal I, Torrejón B, Martínez-Useros J, Madoz-Gurpide J, Rojo F, García-Foncillas J.

Biochim Biophys Acta Rev Cancer. 2017 Dec;1868(2):435-438. doi: 10.1016/j.bbcan.2017.08.005. Epub 2017 Sep 12. Review.

PMID:
28916342
13.

Caveolin-1 is Markedly Downregulated in Patients with Early-Stage Colorectal Cancer.

Torrejón B, Cristóbal I, Rojo F, García-Foncillas J.

World J Surg. 2017 Oct;41(10):2625-2630. doi: 10.1007/s00268-017-4065-9.

PMID:
28560511
14.

Letter to the Editor: Is miR-199b-3p really involved in the migration ability of bone marrow mesenchymal stem cells?

Torrejón B, Cristóbal I, Madoz-Gúrpide J, Rojo F, García-Foncillas J.

J Leukoc Biol. 2017 May;101(5):1067. doi: 10.1189/jlb.2LT0117-034. No abstract available.

PMID:
28468982
15.

The MDS and EVI1 complex locus (MECOM) isoforms regulate their own transcription and have different roles in the transformation of hematopoietic stem and progenitor cells.

Maicas M, Vázquez I, Alis R, Marcotegui N, Urquiza L, Cortés-Lavaud X, Cristóbal I, García-Sánchez MA, Odero MD.

Biochim Biophys Acta Gene Regul Mech. 2017 Jun;1860(6):721-729. doi: 10.1016/j.bbagrm.2017.03.007. Epub 2017 Apr 6.

PMID:
28391050
16.

Comment on 'MicroRNA-214 suppresses growth, migration and invasion through a novel target, high mobility group AT-hook 1, in human cervical and colorectal cancer cells'.

Cristóbal I, Torrejón B, Madoz-Gúrpide J, Rojo F, García-Foncillas J.

Br J Cancer. 2017 Jan;116(3):e7. doi: 10.1038/bjc.2016.409. Epub 2016 Dec 20. No abstract available.

17.

Recent Insights into the Development of Preclinical Trastuzumab- Resistant HER2+ Breast Cancer Models.

Gonzalez-Alonso P, Cristobal I, Zazo S, Martin-Aparicio E, Chamizo C, Madoz-Gurpide J, Rovira A, Eroles P, Lluch A, Albanell J, Rojo F.

Curr Med Chem. 2018;25(17):1976-1998. doi: 10.2174/0929867323666161216144659. Review.

PMID:
27993109
18.

Generation, characterization, and maintenance of trastuzumab-resistant HER2+ breast cancer cell lines.

Zazo S, González-Alonso P, Martín-Aparicio E, Chamizo C, Cristóbal I, Arpí O, Rovira A, Albanell J, Eroles P, Lluch A, Madoz-Gúrpide J, Rojo F.

Am J Cancer Res. 2016 Nov 1;6(11):2661-2678. eCollection 2016.

19.

PP2A plays a key role in inflammation and cancer through tristetraprolin activation.

Cristóbal I, Torrejón B, Madoz-Gúrpide J, Rojo F, García-Foncillas J.

Ann Rheum Dis. 2017 May;76(5):e11. doi: 10.1136/annrheumdis-2016-210684. Epub 2016 Nov 3. No abstract available.

PMID:
27811146
20.

c-Jun N-Terminal Kinase Inactivation by Mitogen-Activated Protein Kinase Phosphatase 1 Determines Resistance to Taxanes and Anthracyclines in Breast Cancer.

Rincón R, Zazo S, Chamizo C, Manso R, González-Alonso P, Martín-Aparicio E, Cristóbal I, Cañadas C, Perona R, Lluch A, Eroles P, García-Foncillas J, Albanell J, Rovira A, Madoz-Gúrpide J, Rojo F.

Mol Cancer Ther. 2016 Nov;15(11):2780-2790. Epub 2016 Sep 6.

Supplemental Content

Loading ...
Support Center